VANCOMYCIN OTOTOXICITY AND NEPHROTOXICITY - A REVIEW

被引：126
|
作者：
BAILIE, GR
NEAL, D
机构：
来源：
MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE | 1988年 / 3卷 / 05期
关键词：
D O I：
10.1007/BF03259891
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：376 / 386
页数：11
相关论文
共 50 条
  • [1] INCREASED NEONATAL VANCOMYCIN TROUGH LEVELS AND INCIDENCE OF OTOTOXICITY/NEPHROTOXICITY IN THE NICU
    Fine, Jenna
    MacLeod, Rachel
    Siu, Anita
    Kooker, Patricia
    Kuo, Yen-Hong
    Bautista, Eduardo
    CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [2] OTOTOXICITY AND NEPHROTOXICITY OF NETILMICIN
    FEDERSPIL, P
    INFECTION, 1976, 4 (04) : 211 - 211
  • [3] OTOTOXICITY OF VANCOMYCIN AND ANALOGS
    BRUMMETT, RE
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 1993, 26 (05) : 821 - 828
  • [4] The Nephrotoxicity of Vancomycin
    Filippone, E. J.
    Kraft, W. K.
    Farber, J. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (03) : 459 - 469
  • [5] VANCOMYCIN NEPHROTOXICITY
    LAU, T
    BARRIERE, SL
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (12): : 907 - 908
  • [6] Insights into ototoxicity - Analogies to nephrotoxicity
    Humes, HD
    OTOTOXICITY: BASIC SCIENCE AND CLINICAL APPLICATIONS, 1999, 884 : 15 - 18
  • [7] Nephrotoxicity and Ototoxicity with Inhaled Tobramycin
    Demas-Clarke, Penny
    Zuberi, Muhammad
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2007, 60 : 62 - 62
  • [8] NEPHROTOXICITY AND OTOTOXICITY OF AMIKACIN IN THE NEWBORN
    PARINI, R
    RUSCONI, F
    CORNACCHIA, L
    MARINI, A
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1981, 7 (04): : 523 - 523
  • [9] Prevention of vancomycin induced nephrotoxicity: a review of preclinical data
    Sepideh Elyasi
    Hossein Khalili
    Shima Hatamkhani
    Simin Dashti-Khavidaki
    European Journal of Clinical Pharmacology, 2013, 69 : 747 - 754
  • [10] Prevention of vancomycin induced nephrotoxicity: a review of preclinical data
    Elyasi, Sepideh
    Khalili, Hossein
    Hatamkhani, Shima
    Dashti-Khavidaki, Simin
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (04) : 747 - 754
12345